These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 20500109)

  • 1. Human menopausal gonadotropin versus highly purified-hMG in controlled ovarian hyperstimulation for in-vitro fertilisation: does purity improve outcome?
    Orvieto R; Meltcer S; Liberty G; Rabinson J; Anteby EY; Nahum R
    Gynecol Endocrinol; 2010 Oct; 26(10):733-5. PubMed ID: 20500109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A spontaneous luteinizing hormone surge is beneficial in women with unexplained infertility undergoing controlled ovarian hyperstimulation without in vitro fertilization.
    Costello MF; Hughes GJ; Garrett DK; Hanjani A; Steigrad SJ
    Int J Fertil Womens Med; 1998; 43(1):28-33. PubMed ID: 9532467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparative randomized controlled study between human follicle- stimulating hormone (FSH-HP) and human menopausal gonadotropins (hMG) in in vitro fertilization].
    Mayenga JM; Belaisch-Allart J; Chouraqui A; Tesquier L; Serkine AM; Cohen J; Plachot M; Mandelbaum J
    Contracept Fertil Sex; 1997 May; 25(5):371-4. PubMed ID: 9273107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modified super-long down-regulation protocol improved the outcome of in vitro fertilization-embryo transfer in infertile patients.
    Gong F; Tang Y; Zhang H; Lu G
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2009 Mar; 34(3):185-9. PubMed ID: 19349670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical comparison of ovarian stimulation and luteal support agents in patients undergoing GnRH antagonist IVF cycles.
    Miller CE; Zbella E; Webster BW; Doody KJ; Bush MR; Collins MG
    J Reprod Med; 2013; 58(3-4):153-60. PubMed ID: 23539885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical outcome following stimulation with highly purified hMG or recombinant FSH in patients undergoing their first treatment cycle of IVF or ICSI.
    Bjercke S; Tanbo T; Abyholm T; Omland A; Opøien HK; Fedorcsak P
    Acta Obstet Gynecol Scand; 2010 Aug; 89(8):1053-60. PubMed ID: 20602599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A retrospective review comparing the use of Gonal-F and Metrodin-HP for in-vitro fertilisation (IVF).
    Lee C; Mak FS; Keith J; Welsh D; Yapp P; Chin R
    Med J Malaysia; 2003 Mar; 58(1):94-8. PubMed ID: 14556331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Ovarian hyperstimulation with menotropins as treatment for unexplained sterility; effect of reproductive characteristics on the results].
    Kably A; Reyes-Cuervo H; Barrón-Vallejo J
    Ginecol Obstet Mex; 1996 Sep; 64():402-5. PubMed ID: 8964541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of highly purified human menopausal gonadotropin vs. recombinant follicle-stimulating hormone in first-cycle in vitro fertilization-intracytoplasmic sperm injection patients.
    Hompes PG; Broekmans FJ; Hoozemans DA; Schats R;
    Fertil Steril; 2008 Jun; 89(6):1685-93. PubMed ID: 17681325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of highly purified human menopausal gonadotropin in intra-uterine insemination.
    Groeneveld E; Kouijzer IJ; Timmermans AJ; Schats R; Hompes PG
    Eur J Obstet Gynecol Reprod Biol; 2011 Feb; 154(2):182-6. PubMed ID: 21093975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Follicular recruitment is reduced in minimal stimulation for controlled ovarian hyperstimulation using purified human menopausal gonadotropin compared with follicle-stimulating hormone.
    Park JK; Clark R; Session DR
    Fertil Steril; 2009 Apr; 91(4 Suppl):1434-6. PubMed ID: 18701097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjunctive leuprolide therapy does not improve cycle fecundity in controlled ovarian hyperstimulation and intrauterine insemination of subfertile women.
    Dodson WC; Walmer DK; Hughes CL; Yancy SE; Haney AF
    Obstet Gynecol; 1991 Aug; 78(2):187-90. PubMed ID: 1906152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Influence of infertility etiology and follicular stimulation protocols on pregnancy outcomes by in vitro fertilization].
    Merviel P; Antoine JM; Alvarez S; Cornet D; Plachot M; Mandelbaum J; Uzan S; Salat-Baroux J
    Contracept Fertil Sex; 1996 Feb; 24(2):157-62. PubMed ID: 8611938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GnRH agonist versus GnRH antagonist in ovarian stimulation: the influence of body mass index on in vitro fertilization outcome.
    Rabinson J; Meltcer S; Zohav E; Gemer O; Anteby EY; Orvieto R
    Fertil Steril; 2008 Feb; 89(2):472-4. PubMed ID: 17582402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective, randomized, controlled trial comparing three different gonadotropin regimens in oocyte donors: ovarian response, in vitro fertilization outcome, and analysis of cost minimization.
    Melo M; Bellver J; Garrido N; Meseguer M; Pellicer A; Remohí J
    Fertil Steril; 2010 Aug; 94(3):958-64. PubMed ID: 19931075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lyophilised hMG versus rFSH in women with unexplained infertility undergoing a controlled ovarian stimulation with intrauterine insemination: a prospective, randomised study.
    Kocak M; Dilbaz B; Demir B; Taşci Y; Tarcan A; Dede S; Haberal A
    Gynecol Endocrinol; 2010 Jun; 26(6):429-34. PubMed ID: 20175705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of LH-containing gonadotropins on diploidy rates in preimplantation embryos: long protocol stimulation.
    Weghofer A; Munné S; Brannath W; Chen S; Tomkin G; Cekleniak N; Garrisi M; Barad D; Cohen J; Gleicher N
    Hum Reprod; 2008 Mar; 23(3):499-503. PubMed ID: 18182396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary hMG (Meropur) versus recombinant FSH plus recombinant LH (Pergoveris) in IVF: a multicenter, prospective, randomized controlled trial.
    Pacchiarotti A; Sbracia M; Frega A; Selman H; Rinaldi L; Pacchiarotti A
    Fertil Steril; 2010 Nov; 94(6):2467-9. PubMed ID: 20537626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treating infertility. Controlled ovarian hyperstimulation using human menopausal gonadotropin in combination with intrauterine insemination.
    Vollenhoven B; Selub M; Davidson O; Lefkow H; Henault M; Serpa N; Hung TT
    J Reprod Med; 1996 Sep; 41(9):658-64. PubMed ID: 8887190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective, randomised, investigator-blind, controlled, clinical study on the clinical efficacy and tolerability of two highly purified hMG preparations administered subcutaneously in women undergoing IVF.
    Alviggi C; Cognigni GE; Morgante G; Cometti B; Ranieri A; Strina I; Filicori M; De Leo V; De Placido G
    Gynecol Endocrinol; 2013 Jul; 29(7):695-9. PubMed ID: 23638621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.